Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor

US7151174B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Oliver Meyer · Ingelheim am Rhein, DE
• Ingo Heddesheimer · Monzingen, DE
• Georg Zerban · Ingelheim am Rhein, DE

Key dates

• Filing date: Nov 1, 2005
• Grant date: Dec 19, 2006
• Expiry date: Nov 1, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention provides a process for making compounds of the general formula I:wherein R2, R4, R5, R11 and Q are defined as in claim 1. The compounds of the general formula I are effective inhibitors of HIV reverse transcriptase.